Spelling suggestions: "subject:"cardiac,"" "subject:"ardiac,""
271 |
The influence of the oxidation status of myoglobin on the oxidative modification of low density lipoproteinBourne, Louise Clare January 1996 (has links)
No description available.
|
272 |
Studies of beta-adrenergic receptors in vivo in humans using the CGP-12177 ligand and positron emission tomographyQing, Feng January 1999 (has links)
No description available.
|
273 |
The pharmacology of the sheep cardiac sarcoplasmic reticulum Ca'2'+-release channelMcGarry, Stephen James January 1994 (has links)
No description available.
|
274 |
The role of Gαâ‚₃ in hypertrophyFinn, Stephen Garret January 2000 (has links)
No description available.
|
275 |
The impact of pre-operative education on recovery following coronary artery bypass surgeryShuldham, Caroline January 2000 (has links)
No description available.
|
276 |
Osmotic shock : modulation of contractile function, pHâ†i and ischaemic damage in the perfused guinea-pig heartBefroy, Douglas Eugene January 2000 (has links)
No description available.
|
277 |
Management of ventricular arrhythmias in the failing heart : a clinical studyBashir, Yaver January 1994 (has links)
No description available.
|
278 |
Physiological and pharmacological models for control of anaesthesiaWorship, George Robin January 1992 (has links)
No description available.
|
279 |
A study of QT interval dynamics using 24-hour Holter monitoringSingh, Jagmeet Premindra January 1996 (has links)
No description available.
|
280 |
Engineering 2D Cardiac Tissues Using Biomimetic Protein Micropatterns Based on the Extracellular Matrix in the Embryonic HeartBatalov, Ivan 01 April 2017 (has links)
Cardiovascular disease is the leading cause of death worldwide. Due to the extremely low natural regeneration rate of heart muscle, development of new therapeutics directed towards heart repair is challenging. A potential approach to regenerate damaged heart is offered by cardiac tissue engineering. Specifically, it aims at engineering cardiac muscle in vitro and implanting it into the site of injury so that it can be integrated into the host tissue and restore the heart’s function. To ensure the effectiveness of this technique, the engineered tissue needs to recapitulate structural and functional properties of the native myocardium. Myocardium consists of laminar sheets of uniaxially aligned cardiac muscle cells (cardiomyocytes) wrapped around the heart. Therefore, achieving high cardiomyocyte alignment in engineered muscle is crucial. In this study we aimed at stimulating cardiomyocyte alignment by mimicking their niche in the embryonic heart. We hypothesized that recapitulating the extracellular cues that guide myocardial development in the embryo can guide cardiac tissue organization in vitro. To test this hypothesis, we imaged the structure of fibronectin – the most abundant protein in embryonic heart’s extracellular matrix (ECM) – and derived a 2D pattern from it that was then microcontact printed onto a substrate to guide cell alignment. We compared chick cardiomyocyte alignment on the biomimetic pattern and line patterns that have been extensively studied in the past. Results revealed a unique cell density-dependent response of cardiomyocytes to the biomimetic pattern that allowed us to elucidate the role of cell-cell and cell-ECM interactions in cardiomyocyte alignment on fibronectin patterns by looking at the effect of local pattern features on alignment and inhibiting N-cadherin-based cell-cell junctions. Further, to engineer more clinically relevant tissues, we differentiated human induced pluripotent stem cells (iPSCs) and embryonic stem cells (ESCs) into cardiomyocytes and seeded them onto the fibronectin patterns. Cardiac tissues produced with these cells showed significant differences compared to the chick tissues due to their immature phenotype. We showed that co-culture with cardiac fibroblasts (CFBs) as well as maturation of iPSC-derived cardiomyocytes (iPSC-CMs) increased tissue alignment, indicating the important role of both of these factors in developing novel methods to engineer functional cardiac tissues.
|
Page generated in 0.0353 seconds